Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Physical Review Letters
|
December 13, 2006
Guided quasicontinuous atom laser
W Guerin, J-F Riou, J P Gaebler, et al.
Anti-Cancer Drug Design
|
January 8, 2000
The development of telomerase inhibitors: the G-quartet approach
J L Mergny, P Mailliet, F Lavelle, et al.
Molecular Pharmacology
|
March 1, 1997
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin
J P Henichart, M J Waring, J F Riou, et al.
Molecular Pharmacology
|
February 3, 1999
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue
C Bailly, X Qu, F Anizon, et al.
Cancer Research
|
September 18, 2001
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506
B Pilch, E Allemand, M Facompré, et al.
Development (Cambridge, England)
|
September 1, 1992
Differential expression and regulation of two distinct fibroblast growth factor receptors during early development of the urodele amphibian Pleurodeles waltl
D L Shi, J J Feige, J F Riou, et al.
International Journal of Obesity (2005)
|
September 20, 2017
Metabolic and genomic adaptations to winter fattening in a primate species, the grey mouse lemur (Microcebus murinus)
J Terrien, M Gaudubois, D Champeval, et al.
The International Journal of Developmental Biology
|
August 1, 1996
What mechanisms drive cell migration and cell interactions in Pleurodeles?
J C Boucaut, L Clavilier, T Darribère, et al.
Anti-Cancer Drug Design
|
June 1, 1992
Further SAR in the new antitumor 1-amino-substituted gamma-carbolines and 5H-benzo[e]pyrido[4,3-b]indoles series
C H Nguyen, F Lavelle, J F Riou, et al.
Biochemical Pharmacology
|
June 15, 1991
Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase
D Lefevre, J F Riou, J C Ahomadegbe, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Physical Review Letters
|
December 13, 2006
Guided quasicontinuous atom laser
W Guerin, J-F Riou, J P Gaebler, et al.
Anti-Cancer Drug Design
|
January 8, 2000
The development of telomerase inhibitors: the G-quartet approach
J L Mergny, P Mailliet, F Lavelle, et al.
Molecular Pharmacology
|
March 1, 1997
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin
J P Henichart, M J Waring, J F Riou, et al.
Molecular Pharmacology
|
February 3, 1999
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue
C Bailly, X Qu, F Anizon, et al.
Cancer Research
|
September 18, 2001
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506
B Pilch, E Allemand, M Facompré, et al.
Development (Cambridge, England)
|
September 1, 1992
Differential expression and regulation of two distinct fibroblast growth factor receptors during early development of the urodele amphibian Pleurodeles waltl
D L Shi, J J Feige, J F Riou, et al.
International Journal of Obesity (2005)
|
September 20, 2017
Metabolic and genomic adaptations to winter fattening in a primate species, the grey mouse lemur (Microcebus murinus)
J Terrien, M Gaudubois, D Champeval, et al.
The International Journal of Developmental Biology
|
August 1, 1996
What mechanisms drive cell migration and cell interactions in Pleurodeles?
J C Boucaut, L Clavilier, T Darribère, et al.
Anti-Cancer Drug Design
|
June 1, 1992
Further SAR in the new antitumor 1-amino-substituted gamma-carbolines and 5H-benzo[e]pyrido[4,3-b]indoles series
C H Nguyen, F Lavelle, J F Riou, et al.
Biochemical Pharmacology
|
June 15, 1991
Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase
D Lefevre, J F Riou, J C Ahomadegbe, et al.
Page
of 11